Koji glycosylceramide commonly contained in Japanese traditional fermented foods alters cholesterol metabolism in obese mice

Hiroshi Hamajima, Masaru Tanaka, Miyuki Miyagawa, Mayuko Sakamoto, Tsuyoshi Nakamura, Teruyoshi Yanagita, Megumi Nishimukai, Susumu Mitsutake, Jiro Nakayama, Koji Nagao, Hiroshi Kitagaki

Research output: Contribution to journalArticle

Abstract

Koji, which is manufactured by proliferating non-pathogenic fungus Aspergillus oryzae on steamed rice, is the base for Japanese traditional fermented foods. We have revealed that koji and related Japanese fermented foods and drinks such as amazake, shio-koji, unfiltered sake and miso contain abundant glycosylceramide. Here, we report that feeding of koji glycosylceramide to obese mice alters the cholesterol metabolism . Liver cholesterol was significantly decreased in obese mice fed with koji glycosylceramide. We hypothesized that their liver cholesterol was decreased because it was converted to bile acids. Consistent with the hypothesis, many bile acids were increased in the cecum and feces of obese mice fed with koji glycosylceramide. Expressions of CYP7A1 and ABCG8 involved in the metabolism of cholesterol were significantly increased in the liver of mice fed with koji glycosylceramide. Therefore, it was considered that koji glycosylceramide affects the cholesterol metabolism in obese mice.

Original languageEnglish
Pages (from-to)1514-1522
Number of pages9
JournalBioscience, Biotechnology and Biochemistry
Volume83
Issue number8
DOIs
Publication statusPublished - Jan 1 2019

Fingerprint

Obese Mice
Metabolism
Cholesterol
Food
Liver
Bile Acids and Salts
Aspergillus oryzae
Soy Foods
Cecum
Aspergillus
Fungi
Feces

All Science Journal Classification (ASJC) codes

  • Biotechnology
  • Analytical Chemistry
  • Biochemistry
  • Applied Microbiology and Biotechnology
  • Molecular Biology
  • Organic Chemistry

Cite this

Koji glycosylceramide commonly contained in Japanese traditional fermented foods alters cholesterol metabolism in obese mice. / Hamajima, Hiroshi; Tanaka, Masaru; Miyagawa, Miyuki; Sakamoto, Mayuko; Nakamura, Tsuyoshi; Yanagita, Teruyoshi; Nishimukai, Megumi; Mitsutake, Susumu; Nakayama, Jiro; Nagao, Koji; Kitagaki, Hiroshi.

In: Bioscience, Biotechnology and Biochemistry, Vol. 83, No. 8, 01.01.2019, p. 1514-1522.

Research output: Contribution to journalArticle

Hamajima, H, Tanaka, M, Miyagawa, M, Sakamoto, M, Nakamura, T, Yanagita, T, Nishimukai, M, Mitsutake, S, Nakayama, J, Nagao, K & Kitagaki, H 2019, 'Koji glycosylceramide commonly contained in Japanese traditional fermented foods alters cholesterol metabolism in obese mice', Bioscience, Biotechnology and Biochemistry, vol. 83, no. 8, pp. 1514-1522. https://doi.org/10.1080/09168451.2018.1562877
Hamajima, Hiroshi ; Tanaka, Masaru ; Miyagawa, Miyuki ; Sakamoto, Mayuko ; Nakamura, Tsuyoshi ; Yanagita, Teruyoshi ; Nishimukai, Megumi ; Mitsutake, Susumu ; Nakayama, Jiro ; Nagao, Koji ; Kitagaki, Hiroshi. / Koji glycosylceramide commonly contained in Japanese traditional fermented foods alters cholesterol metabolism in obese mice. In: Bioscience, Biotechnology and Biochemistry. 2019 ; Vol. 83, No. 8. pp. 1514-1522.
@article{620b1b5d3f5c4ee8b75081c324f18156,
title = "Koji glycosylceramide commonly contained in Japanese traditional fermented foods alters cholesterol metabolism in obese mice",
abstract = "Koji, which is manufactured by proliferating non-pathogenic fungus Aspergillus oryzae on steamed rice, is the base for Japanese traditional fermented foods. We have revealed that koji and related Japanese fermented foods and drinks such as amazake, shio-koji, unfiltered sake and miso contain abundant glycosylceramide. Here, we report that feeding of koji glycosylceramide to obese mice alters the cholesterol metabolism . Liver cholesterol was significantly decreased in obese mice fed with koji glycosylceramide. We hypothesized that their liver cholesterol was decreased because it was converted to bile acids. Consistent with the hypothesis, many bile acids were increased in the cecum and feces of obese mice fed with koji glycosylceramide. Expressions of CYP7A1 and ABCG8 involved in the metabolism of cholesterol were significantly increased in the liver of mice fed with koji glycosylceramide. Therefore, it was considered that koji glycosylceramide affects the cholesterol metabolism in obese mice.",
author = "Hiroshi Hamajima and Masaru Tanaka and Miyuki Miyagawa and Mayuko Sakamoto and Tsuyoshi Nakamura and Teruyoshi Yanagita and Megumi Nishimukai and Susumu Mitsutake and Jiro Nakayama and Koji Nagao and Hiroshi Kitagaki",
year = "2019",
month = "1",
day = "1",
doi = "10.1080/09168451.2018.1562877",
language = "English",
volume = "83",
pages = "1514--1522",
journal = "Bioscience, Biotechnology and Biochemistry",
issn = "0916-8451",
publisher = "Japan Society for Bioscience Biotechnology and Agrochemistry",
number = "8",

}

TY - JOUR

T1 - Koji glycosylceramide commonly contained in Japanese traditional fermented foods alters cholesterol metabolism in obese mice

AU - Hamajima, Hiroshi

AU - Tanaka, Masaru

AU - Miyagawa, Miyuki

AU - Sakamoto, Mayuko

AU - Nakamura, Tsuyoshi

AU - Yanagita, Teruyoshi

AU - Nishimukai, Megumi

AU - Mitsutake, Susumu

AU - Nakayama, Jiro

AU - Nagao, Koji

AU - Kitagaki, Hiroshi

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Koji, which is manufactured by proliferating non-pathogenic fungus Aspergillus oryzae on steamed rice, is the base for Japanese traditional fermented foods. We have revealed that koji and related Japanese fermented foods and drinks such as amazake, shio-koji, unfiltered sake and miso contain abundant glycosylceramide. Here, we report that feeding of koji glycosylceramide to obese mice alters the cholesterol metabolism . Liver cholesterol was significantly decreased in obese mice fed with koji glycosylceramide. We hypothesized that their liver cholesterol was decreased because it was converted to bile acids. Consistent with the hypothesis, many bile acids were increased in the cecum and feces of obese mice fed with koji glycosylceramide. Expressions of CYP7A1 and ABCG8 involved in the metabolism of cholesterol were significantly increased in the liver of mice fed with koji glycosylceramide. Therefore, it was considered that koji glycosylceramide affects the cholesterol metabolism in obese mice.

AB - Koji, which is manufactured by proliferating non-pathogenic fungus Aspergillus oryzae on steamed rice, is the base for Japanese traditional fermented foods. We have revealed that koji and related Japanese fermented foods and drinks such as amazake, shio-koji, unfiltered sake and miso contain abundant glycosylceramide. Here, we report that feeding of koji glycosylceramide to obese mice alters the cholesterol metabolism . Liver cholesterol was significantly decreased in obese mice fed with koji glycosylceramide. We hypothesized that their liver cholesterol was decreased because it was converted to bile acids. Consistent with the hypothesis, many bile acids were increased in the cecum and feces of obese mice fed with koji glycosylceramide. Expressions of CYP7A1 and ABCG8 involved in the metabolism of cholesterol were significantly increased in the liver of mice fed with koji glycosylceramide. Therefore, it was considered that koji glycosylceramide affects the cholesterol metabolism in obese mice.

UR - http://www.scopus.com/inward/record.url?scp=85068619596&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85068619596&partnerID=8YFLogxK

U2 - 10.1080/09168451.2018.1562877

DO - 10.1080/09168451.2018.1562877

M3 - Article

C2 - 30595103

AN - SCOPUS:85068619596

VL - 83

SP - 1514

EP - 1522

JO - Bioscience, Biotechnology and Biochemistry

JF - Bioscience, Biotechnology and Biochemistry

SN - 0916-8451

IS - 8

ER -